A UK registry followed 1,917 patients with familial adenomatous polyposis born after 1935, recording 364 deaths against 28 expected. Relatives found by family screening had mortality comparable to the general population, with a median SMR of 0.66 against 11.09 for those presenting with symptoms. Colorectal disease fell from 64% of deaths before 2001 to 31% after 2013, while duodenal and gastric deaths rose.
Why it is interesting: Relatives found by screening now die at general population rates, and remaining deaths have moved to upper gastrointestinal sites.
Abstract — the authors' own words, CC BY
Background
The impact of modern management on life expectancy in familial adenomatous polyposis (FAP) remains sparsely reported, and recent treatment effects on disease-related causes of death are unclear. This study provides an updated assessment of life expectancy and mortality causes. Methods
Patients born after January 1935 were identified from a prospectively maintained registry with supplementary clinical record review. Retrospective life table analysis compared mortality with a matched UK Office for National Statistics population. Causes of death were analysed by era and stratified by presentation type - newly presenting patients versus screen-detected relatives identified through family screening. Results
Among 1917 patients with FAP, 364 deaths occurred versus 28 expected in the general population. Screen-detected relatives had consistently lower mortality, comparable to the general population (median SMR 0.66; SMR Conclusion
Recent FAP cohorts now have mortality comparable to the general population. Although colorectal mortality has declined, gastroduodenal and non-FAP-related causes have increased, underscoring the need for continued surveillance and broader long-term management strategies.
Cite this item
BibTeX
Free sign-up. A digest of the new papers twice a week, grouped by domain.